Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dick C Chan

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Current Opinion in Lipidology|February 16, 2010
Genetic determinants of apolipoprotein B-100 kineticsTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
Journal of the American Heart Association|March 23, 2019
Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering TherapyDick C Chan, Gerald F Watts, Blai Coll, et al.
Journal of Lipid Research|March 25, 2006
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasmaMinh N Nguyen, Dick C Chan, Kevin P Dwyer, et al.
Clinical Science (London, England : 1979)|March 26, 2003
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndromeDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Diabetes|July 30, 2002
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemiaDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Endocrinology|November 23, 2007
Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese menDick C Chan, Gerald F Watts, Jian Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2008
Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndromeDick C Chan, Gerald F Watts, Esther M M Ooi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 2009
Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese menDick C Chan, P Hugh R Barrett, Esther M M Ooi, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesityDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Chemistry|August 29, 2009
Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?Dick C Chan, Gilles Lambert, P Hugh R Barrett, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Current Opinion in Lipidology|February 16, 2010
Genetic determinants of apolipoprotein B-100 kineticsTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
Journal of the American Heart Association|March 23, 2019
Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering TherapyDick C Chan, Gerald F Watts, Blai Coll, et al.
Journal of Lipid Research|March 25, 2006
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasmaMinh N Nguyen, Dick C Chan, Kevin P Dwyer, et al.
Clinical Science (London, England : 1979)|March 26, 2003
Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndromeDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Diabetes|July 30, 2002
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemiaDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Endocrinology|November 23, 2007
Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese menDick C Chan, Gerald F Watts, Jian Wang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2008
Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndromeDick C Chan, Gerald F Watts, Esther M M Ooi, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 2009
Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese menDick C Chan, P Hugh R Barrett, Esther M M Ooi, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesityDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Clinical Chemistry|August 29, 2009
Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 catabolism?Dick C Chan, Gilles Lambert, P Hugh R Barrett, et al.
Pageof 18